Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Benoît Trottier
Dolutegravir/Abacavir/Lamivudine Versus Current ART in Virally Suppressed Patients (STRIIVING): A 48-Week, Randomized, Non-Inferiority, Open-Label, Phase IIIb Study
Antiviral Therapy
Infectious Diseases
Pharmacology
Antiretroviral Therapy for Adults Infected With HIV: Guidelines for Health Care Professionals From the Quebec HIV Care Committee
Canadian Journal of Infectious Diseases and Medical Microbiology
Infectious Diseases
Microbiology
Related publications
Lipid Profile Improvement in Virologically Suppressed HIV-1-infected Patients Switched to Dolutegravir/Abacavir/Lamivudine: Data From the SCOLTA Project
Infection and Drug Resistance
Infectious Diseases
Pharmacology
Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
Long-Term Safety and Tolerability of Oral Tofacitinib in Patients With Crohn’s Disease: Results From a Phase 2, Open-Label, 48-Week Extension Study
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
A Multi-National, Randomised, Open-Label, Parallel, Phase III Non-Inferiority Study Comparing NK105 and Paclitaxel in Metastatic or Recurrent Breast Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
Efficacy of Bimin Decoction for Patients With Perennial Allergic Rhinitis: An Open-Label Non-Inferiority Randomized Controlled Trial
Trials
Medicine
Pharmacology
Prospective Open-Label Study of 48-Week Subcutaneous Administration of Mepolizumab in Japanese Patients With Severe Eosinophilic Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
96-Week Results of Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Plus Efavirenz, in Antiretroviral-Naive, HIV-1-infected Adults: ASSERT Study
Antiviral Therapy
Infectious Diseases
Pharmacology
Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study
Clinical Therapeutics
Pharmacology
Dihydroartemisinin-Piperaquine Versus Chloroquine to Treat Vivax Malaria in Afghanistan: An Open Randomized, Non-Inferiority, Trial
Malaria Journal
Parasitology
Infectious Diseases